[EN] A COMPOUND HAVING INHIBITORY ACTIVITY AGAINST KRAS G12D MUTATION<br/>[FR] COMPOSÉ AYANT UNE ACTIVITÉ INHIBITRICE CONTRE LA MUTATION KRAS G12D
申请人:TAIHO PHARMACEUTICAL CO LTD
公开号:WO2021107160A1
公开(公告)日:2021-06-03
The present invention relates to compounds of formula (1) as shown below having inhibitory activity against KRAS G12D mutation or a salt thereof, and relates to a pharmaceutical composition comprising these compounds as active ingredient.